Does Ganirelix work?
Yes, in controlled trials, including one of 313 women.
Approval rested on randomized phase 3 trials against the standard long GnRH agonist protocol, including the North American trial cited here (313 women, ganirelix versus leuprolide), which found similar pregnancy rates with a shorter, simpler course. The label adds a 332-patient dose-finding trial and a larger open-label randomized trial against a GnRH agonist in which 463 women received ganirelix. 24
The North American phase 3 trial randomized 313 women at IVF centers. One group got ganirelix, started during stimulation. The other got leuprolide, started in the cycle before. Clinical pregnancy rates per attempt were 35.4% with ganirelix and 38.4% with leuprolide. Ongoing pregnancy rates were 30.8% and 36.4%. None of these gaps was statistically significant. Cycles with ganirelix were shorter. They used fewer shots. They gave slightly fewer eggs (11.6 versus 14.1 on average). Moderate and severe reactions at the injection site were less common with ganirelix. 2
The prescribing information sums up two more trials. One was a double-blind study of doses in 332 women. The other was an open-label randomized study in which 463 women received ganirelix, with a GnRH agonist as the reference treatment. Since then, plans built on ganirelix or cetrorelix have become the default in most IVF programs. One reason is that they allow a GnRH agonist as the ovulation trigger. That sharply cuts the risk of ovarian hyperstimulation syndrome (OHSS). 4
Evidence checklist
- Randomised controlled trial Randomized vs leuprolide protocol
- Human study over 100 people North American trial, 313 women
- More than one research group North American and European trials
- Clinical outcomes, not surrogate markers Pregnancy rates measured
- Human safety data beyond case reports Birth anomaly rates similar to agonist cycles
More on Ganirelix
Citations
- Fyremadel (ganirelix acetate) prescribing information drugs.com
- Fluker 2001, Fertility and Sterility: efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation (North American Ganirelix Study Group) doi.org
- Organon: ganirelix acetate injection product page organonpro.com
- Organon: ganirelix acetate injection prescribing information organon.com
Reference information only, not medical advice. Drawn from the Ganirelix article, fact-checked against the cited sources. No dosing anywhere on this site.